News
Archive
Emporos and InterLink AI Partner, develop only POS-Integrated lighted will-call solution
Phase Four partners with Redwire to expand space propulsion offerings and deliver Hall Effect Thrusters
Ventyx Biosciences announces positive preclinical data for CNS-penetrant NLRP3 inhibitor VTX3232 demonstrating reversal of obesity and improvements in cardiometabolic and inflammatory markers
Resolve Therapeutics publishes results of RSLV-132 Phase 2 long COVID study
Finally, Graphene electronic devices available for all
DARPA awards Phase Four $14.9M contract to develop Air Breathing Electric Propulsion for Very Low Earth Orbit operations
Back To NewsOctober 17, 2017
Trellis Bioscience
Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.